It has been demonstrated that individuals with certain polymorphisms in the NEP gene have an increased risk for AD (Helisalmi et al., 2004) and the susceptibility to AD is even higher when insulin-degrading enzyme (IDE), another Aβ-degrading enzyme, also shows a polymorphism (Vepsalainen et al., 2009). Here, IDE is linked to Alzheimer disease.